variant in a white female patient. Furthermore, there have been a number of cases of a histologically similar tumor from Western authors reported as "NC-CEOT" [7, 8] and "atypical CEOT" [9, 10] , or other more well-known tumors such as central odontogenic fibroma (COdF) [11] [12] [13] [14] [15] [16] [17] and odontogenic myxoma [18] .
We concur with the suggestion by Eversole [15] in 2011 that the NCLC variant be placed under the umbrella of COdF. This behaves more like COdF (non-aggressive [4, 13, 15, 19] ) than CEOT (locally aggressive [2, 4, [19] [20] [21] ). COdF frequently involves the anterior-premolar region (77% of all cases and 91% of maxillary cases [4, 13, [22] [23] [24] [25] ) [3, 14, 21, 26] . This is in contrast to CEOT, which arises most often in the mandible (59% [2]-74% [27] ), particularly the posterior area (82% [19, 20, 26] ) [1] . A notable predilection for the anterior maxilla has been noted for the NCLC variant [1, 2, [4] [5] [6] . COdF is more than twice as common in females [3, 13, 19, 21, 22, [24] [25] [26] , while there is almost equal distribution of CEOT between males and females [2, 19, 20, 26, 27] . As stated above, the NCLC variant shows a strong female predilection. Almost 60% of CEOTs show a dentigerous relationship to an impacted tooth [1, 20, 27] ; more than half of such cases involve mandibular molars [1, 19, 20, 26] , whereas only 11% [22] to 27% [25] of COdFs are associated with the tooth crown. Most COdFs reside in a peri-or interradicular location [3, 4, 13-15, 22-26, 28] , and the NCLC variant has been defined as "root-associated" [1, 2, [4] [5] [6] . Root resorption is common in COdF (29% [13, 25] to 76% [4] ) [15, 21, 23, 26] , but uncommon in CEOT (4% [19, 27] to 13% [2] ). About 70% of cases of the NCLC variant have exhibited this radiographic characteristic [4] . The presence of a palatal perforation of maxillary lesions anterior to the first molar (25% [24] to 80% [28] ) is highly suggestive of COdF [4, 15, 22, 23, 26] . This unique COdF-associated clinical sign has been recorded in more than half of cases of the NCLC variant [4, 6] . CEOT recurs at a significantly higher rate (up to 20%) [2, 3, 19, 20, 26, 29] when compared with COdF (4%) [29] . There is no well-documented tendency for the NCLC variant to recur [1, 2, 4, 6] , and only a rare recurrence is to be expected [5] . The first author to have publicly suggested the concept of NC-CEOT-like COdF was Dunlap [13] in 1999, but almost 2 decades previously Gardner [11] had called attention to COdF containing eosinophilic globules, creating confusion with CEOT. As with Smith et al. [10] , Odell and Morgan [30] illustrated NC-CEOT with microscopic features of COdF in their 1998 textbook. This diagnostic problem was further discussed in 2009 [19] and 2011 [3, 15] , respectively. Neville et al. [26] expressed similar frustration in the 4th edition of their widely used textbook. In 2011, Eversole [15] suggested consideration of the term "amyloid/dendritic cell-associated, amyloid/CD1a-associated or amyloid variant" to describe NCLC-CEOT-like COdF. Four years later, Carolina et al. [17] chose to use the term "amyloid/dendritic cell-associated variant" in the title of their abstract. Very recently, Zhou and Li [4] provided additional support for Eversole's suggestion by using the term "amyloid variant" in their series of four new cases. This variant accounts for 16% [15] to 35% [4] of COdFs.
Since the first description by Smith et al. [7] in 1977, NC-CEOT has been well documented [8, 10, 21, [30] [31] [32] [33] [34] [35] [36] , and the 1992 World Health Organization blue book recognized it specifically [37] . Because of the contradictory prefix "NC (non-calcifying)-C (calcifying)," a number of authors favored the modified term "NC-EOT" [5, 7, 31, 36] . To our knowledge, only two reports of NC-CEOT have briefly mentioned that LCs were absent [33, 34] . Although LC markers were not examined in most cases, several articles of conventional CEOT with small amounts of LCs have been published [4, 6, [38] [39] [40] . Taken together, the presence or absence of LCs may not be primarily related to calcification in CEOT [39] , and too much emphasis is probably placed on their participation in lesion formation. Praetorius [19] concluded that progressive calcification is usually seen in large tumors of long duration.
In summary, the profile of the NCLC variant is quite different from that of classic CEOT [1, 4] . It seems advantageous to reconsider the categorization of this intriguing tumor as COdF [4, 15] , in terms of both clinical presentation and pathological features. A supporting observation is that the COdF epithelium frequently contains substantial numbers of LCs (50% [41] to 100% [4, 42] of tested cases) [16] . Additional support comes from Eversole's work that COdF-amyloid is odontogenic ameloblast-associated protein [15] , which has been detected in CEOT-amyloid [3, 4, 19, 26] . Of particular interest is that epithelial/fibroblastic cells and globular deposits positive for amelogenin are reportedly scattered in COdF [43] . Multi-institutional cooperation and/or international collaboration is needed for comparative study of the NCLC variant of CEOT and the amyloid variant of COdF.
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